{"product_id":"non-melanoma-skin-cancer-treatment-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2022-2027","title":"Non-Melanoma Skin Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027","description":"\u003cp\u003eNon-Melanoma Skin Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027\u003c\/p\u003e\n\n\u003cp\u003eThe global non-melanoma skin cancer treatment market size reached US$ 504.6 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 692.9 Million by 2027, exhibiting a growth rate (CAGR) of 5.54% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemicon different end use sectors. These insights are included in the report as a major market contributor.\u003c\/p\u003e\n\n\u003cp\u003eNon-melanoma skin cancer (NMSC) refers to the abnormal growth of malignant cells in the upper layer of the skin. Some of the common types of NMSC include basal cell, merkle cell and squamous cell carcinoma and cutaneous T-cell lymphoma. It is primarily characterized by the development of firm lumps or scaly patches on the skin. The treatment methodologies involve the removal of cancer cells through surgical procedures, including micrographic surgery, laser therapy and cryotherapy, and various non-surgical treatments, such as photodynamic therapy (PDT), radiotherapy and electrotherapy.\u003c\/p\u003e\n\n\u003cp\u003eThe increasing prevalence of skin cancer and the rising geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the available treatment alternatives for NMSC is also stimulating the market growth. In comparison to the traditionally used therapies, superficial radiation therapy has reduced side-effects on the patient’s body and can be conducted through innovative portable devices. These devices are also used for early diagnosis of skin lesions with high accuracy and sensitivity. Additionally, various technological advancements, such as the development of electronic brachytherapy (eBx), are acting as other growth-inducing factors. eBx is a painless and non-invasive targeted low-energy radiation therapy that requires a shorter treatment course and minimizes the risks of radiation exposure to the nearby healthy tissues. Other factors, including rising healthcare expenditures of individuals and government funding for clinical trials, along with extensive research and development (R\u0026amp;D) activities, are anticipated to drive the market further.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global non-melanoma skin cancer treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on treatment type, indication and end use.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Treatment Type:\u003c\/p\u003e\n\n\u003cp\u003eChemotherapy\u003cbr\u003e\nRadiation Therapy\u003cbr\u003e\nPhotodynamic Therapy\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Indication:\u003c\/p\u003e\n\n\u003cp\u003eBasal Cell Carcinoma\u003cbr\u003e\nT-Cell Lymphoma\u003cbr\u003e\nSquamous Cell Carcinoma\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by End Use:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nSpecialty Clinics\u003cbr\u003e\nAmbulatory Surgery Centers\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe report has also analysed the competitive landscape of the market with some of the key players being Accuray Incorporated, Almirall S.A., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Elekta AB, Eli Lilly and Company, F. Hoffmann-La Roche AG, Icad Inc., Merck \u0026amp; Co. Inc., Novartis AG, Sun Pharmaceutical Industries Limited and Varian Medical Systems Inc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global non-melanoma skin cancer treatment market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global non-melanoma skin cancer treatment market?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat is the breakup of the market based on the treatment type?\u003cbr\u003e\nWhat is the breakup of the market based on the indication?\u003cbr\u003e\nWhat is the breakup of the market based on the end use?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global non-melanoma skin cancer treatment market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2022 \/ 143 Pages \/ MCW16238597","offer_id":47653736055090,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/non-melanoma-skin-cancer-treatment-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2022-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}